Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer

European Urology

Volumn 43, Issue 1, 2003, Pages 53-62

  Puente, D ^a   Malats, N ^a   Cecchini, L ^b   Tardon A ^c   Garcia Closas R ^d   Serra, C ^e   Carrato, A ^f   Sala, M ^a   Boixeda, R ^a   Dosemeci, M ^g   Real, F X ^a   Kogevinas, M ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c UNIVERSITY OF OVIEDO   (Spain)

^d HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^e Department of Pediatrics   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^g NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bladder cancer; Pathological characteristics; Sex ratio; Stage; Treatment; Women

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER STAGING; CANCER THERAPY; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; SEX DIFFERENCE; SEX RATIO; SPAIN; TRANSURETHRAL RESECTION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; SEX DISTRIBUTION; SEX FACTORS; URINARY BLADDER NEOPLASMS;

EID: 12244291910     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(02)00496-7     Document Type: Article

References (38)

1. Silverman D, Morrison A, Devesa S, Bladder cancer. In: Schottenfeld D, Fraumeni J, editors, Cancer Epidemiology and Prevention, 2nd ed. New York: Oxford University Press Inc., 1996. p. 1156-79.
2. Hartge P, Harvey EB, Linehan WM, Silverman DT, Sullivan JW, Hoover RN, Fraumeni Jr JF. Unexplained Excess Risk of Bladder Cancer in Men. J Natl Cancer Inst 1990;82:1636-40.
3. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41.
4. Ruiz Cerda JL, Alfonso Gil R, Domenech Ferrando E, Pascual Bueno J, Vera Donoso CD, Martinez Jabaloyas J, Jimenez Cruz JF. Evolución temporal (1960-1990) de la mortalidad y la razón de masculinidad en España del cáncer vesical. Acta Urol Esp 1995;19:196-202.
5. Miller AB. The Etiology of Bladder Cancer from the Epidemiological Viewpoint. Cancer Res 1977;37:2939-42.
6. Matanoski GM. Bladder Cancer Epidemiology. Epidemiol Rev 1981; 3:203-29.
7. Van der Poel HG, Mungan NA, Witjes JA. Bladder cancer in women. Int Urogynecol J Pelvic Floor Dysfunct 1999;10:207-12.
8. Hickey D, Soloway MS. Does invasive bladder cancer differ between women and men? Urology 1988;32:183-5.
9. Johansson SL, Cohen SM. Epidemiology and etiology of bladder cancer. Semin Surg Oncol 1997;13:291-8.
10. Kiemeney LA, Coebergh JW, Koper NP, Van der Heijden LH, Pauwels RP, Schapers RF, et al. Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975-1989. Eur J Cancer 1994;30A:1134-7.
11. Fleshner NE, Herr HW, Stewart AK, Murphy GP, Mettlin C, Menck HR. The National Cancer Data Base report on bladder carcinoma: the American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1996;78:1505-13.
12. Mungan N, Kiemeney L, Van Dick J, Van der Poel H, Witjes J. Gender differences in stage distribution of bladder cancer. Urology 2000;55:368-71.
13. Romero JA, Alvarez-Vijande R, Gutierrez R, Vendrell R, Gil-Vernet Jr JM, Carretero P. Invasive bladder cancer in women. Arch Esp Urol 1992;45:837-9.
14. Laor E, Schiffman Z, Reid RE, Tolia BM, Freed SZ. Sex-dependent variations in natural history of transitional cell carcinoma of bladder. Urology 1984;23:237-9.
15. Jensen OM, Wahrendorf J, Blettner M, Knudsen JB, Sorensen BL. The Copenhagen case-control study of bladder cancer: role of smoking in invasive and non-invasive bladder tumours. J Epidemiol Commun Health 1987;41:30-6.
16. Sturgeon SR, Hartge P, Silverman DT, Kantor AF, Linehan WM, Lynch C, et al. Associations between bladder cancer risk factors and tumor stage and grade at diagnosis. Epidemiology 1994;5: 218-25.
17. Aben KK, Kiemeney LA. Epidemiology of bladder cancer. Eur Urol 1999;36:660-72.
18. Micheli A, Mariotto A, Giorgi Rossi A, Gatta G, Muti P. The Prognostic Role of Gender in Survival of Adult Cancer Patients. Eur J Cancer 1998;34:2271-8.
19. Mungan NA, Aben KK, Schoenberg MP, Visser O, Coebergh JW, Witjes JA, et al. Gender differences in stage-adjusted bladder cancer survival. Urology 2000;55:876-80.
20. AJCC. International Classification of Diseases. 9th revision. code 188, 1993.
21. AJCC. Urinary bladder: AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven; 1997.
22. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998;22:1435-48.
23. Ash J. Epithelial tumors of the bladder. J Urol 1940;44:135-45.
24. Van der Meijden AP, Brausi M, Zambon V, Kirkels W, de Balincourt C, Sylvester R. Intravesical instillation of epirubicin, bacillus Calmette-Guerin and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder: a European Organization for Research and Treatment of Cancer genito-urinary group randomized phase III trial. J Urol 2001;166: 476-81.
25. Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA, et al. Maintenance Bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol 2000;163:1124-9.
26. Baniel J. Bladder cancer in women. Int Urogynecol J Pelvic Floor Dysfunct 1999;10:399-404.
27. Rubben H, Lutzeyer W, Fischer N, Deutz F, Lagrange W, Giani G. Natural history and treatment of low and high risk superficial bladder tumors. J Urol 1988;139:283-5.
28. Fernandez Fernandez A, Garcia Escudero C, Fernandez Ruiz M, Dominguez Benito P, Gil Fabra J, Otero Mauricio G. Influencia de la diferencia del sexo en la agresividad biológica del tumor urotelial vesical en su primer diagnóstico. Acta Urol Esp 1998;22:34-6.
29. Kiemeney LA, Witjes JA, Verbeek AL, Heijbroek RP, Debruyne FM. The clinical epidemiology of superficial bladder cancer: Dutch South-East Cooperative Urological Group. Br J Cancer 1993;67:806-12.
30. Parkin D, Whelan S, Ferlay J, Raymond L, Young J, editors, Cancer incidence in Five Continents. Lyon: IARC Scientific Publications, no. 143; 1997.
31. Hoke GP, Stone BA, Klein L, Williams KN. The influence of gender on incidence and outcome of patients with bladder cancer in Harlem. J Natl Med Assoc 1999;91:144-8.
32. Knowles M, Molecular genetics of bladder cancer: pathways of development and progression. In: Oliver RTD, Coptcoat MJ, editors, Bladder cancer, vol 31. New York: Cold Spring Harbor Laboratory Press; 1998. p. 49-76.
33. Kantor AF, Hartge P, Hoover RN, Fraumeni Jr JF. Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder. Cancer Res 1988;48:3853-5.
34. Metts MC, Metts JC, Milito SJ, Thomas Jr CR. Bladder cancer: a review of diagnosis and management. J Natl Med Assoc 2000; 92:285-94.
35. Anton-Culver H, Lee-Feldstein A, Taylor TH. The association of bladder cancer risk with ethnicity, gender, and smoking. Ann Epidemiol 1993;3:429-33.
36. Abel PD, Hall RR, Williams G. Should pT1 transitional cell cancers of the bladder still be classified as superficial? Br J Urol 1988;62: 235-9.
37. Mulders PF, Meyden AP, Doesburg WH, Oosterhof GO, Debruyne FM. Prognostic factors in pTa-pT1 superficial bladder tumours treated with intravesical instillations. The Dutch South-Eastern Urological Collaborative Group. Br J Urol 1994;73:403-8.
38. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodriguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000;163:73-8.